Biodefense Market

Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country?s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
Biodefense Market contains market size and forecasts of Biodefense in Global, including the following market information:
Global Biodefense Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biodefense market was valued at 1177.1 million in 2021 and is projected to reach US$ 1888.5 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anthrax Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biodefense include Emergent Biosolutions, Hytest, GSK, Sanofi, PharmAthene, Bavarian Nordic, SIGA Technologies, Arbutus Biopharma and DynPort Vaccine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biodefense companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biodefense Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biodefense Market Segment Percentages, by Type, 2021 (%)
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Global Biodefense Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biodefense Market Segment Percentages, by Application, 2021 (%)
US Military Market
US Civilian Market
Non - US Market
Global Biodefense Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biodefense Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biodefense revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biodefense revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals